Back to Journals » Therapeutics and Clinical Risk Management » Volume 14

Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson's disease: systematic review, meta-analysis, and economic evaluation

Total article views   HTML views PDF downloads Totals
14,485 Dovepress* 12,729+ 1,588 14,317
PubMed Central* 1,756 541 2,297
Totals 14,485 2,129 16,614
*Since 16 April 2018

View citations on PubMed Central and Google Scholar